Cameron Turtle Net Worth & Insider Trades

Cameron Turtle - Chief Business Officer, Eidos Therapeutics, Inc

As of December 16, 2020

What is Cameron Turtle's Net Worth?

The current estimated net worth of Eidos Therapeutics, Inc's Chief Business Officer, Cameron Turtle, is estimated to be about $14.72M . Cameron Turtle owns about 50,621 units of Eidos Therapeutics, Inc common stock. In the last year at Eidos Therapeutics, Inc, Cameron Turtle has sold an estimated value of $8.21M worth.

What is Cameron Turtle's Past Insider Trading?

Cameron Turtle's largest purchase order was 26,294 units , worth over $363.99K on December 16, 2020. Cameron Turtle's largest sale order was 26,294 units , worth over $2.94M on December 16, 2020. In total, Cameron Turtle has made about 13 transactions over a year of their time at Eidos Therapeutics, Inc. Cameron Turtle usually trades in November, with the busiest year in 2020.

Cameron Turtle

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What was Cameron Turtle's Salary in 2020?

As Chief Business Officer of Eidos Therapeutics, Inc, Cameron Turtle has a total base salary of $400,000 . Cameron Turtle received compensation valued at about $4,561,482 in 2020 after becoming Chief Business Officer.

What is Cameron Turtle's' Mailing Address?

  • Mailing address is C/o Eidos Therapeutics, Inc. 101 Montgomery Street, Suite 2550 San Francisco CA 94104 CA

What are Eidos Therapeutics, Inc's Past Insider Trades?

Eidos Therapeutics, Inc's most recent insider trade came on January 26, 2021 by Bridgebio Pharma Inc who bought 14,428,836 units worth $0 . In the last 3 years, insiders at Eidos Therapeutics, Inc have sold an estimated value of $34.74M and bought an estimated value of $352.62M worth of shares. Insider trading is most common in June, with the busiest year in 2019. The most active traders at the company are Jonathan Fox, See Remarks,  Cameron Turtle, Chief Business Officer,  and Christine Siu, CFO and Secretary .

Eidos Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...